Ph.D. Student
Molecular Biology · Iran · 2025-09-03
Proposed Endeavor
The petitioner proposes to combine molecular biology methods with innovative drug delivery systems to enhance immune recognition of cancer cells. Her work focuses on developing next-generation immunotherapies that provide highly effective and less toxic treatment options for patients.
Framework Evaluation
3 of 3 criteria metThe endeavor addresses cancer, a leading cause of death in the U.S., and aligns with the Cancer Moonshot initiative.
The petitioner has authored 4 peer-reviewed articles with 36 citations and holds an advanced degree in medical immunology.
USCIS determined that the petitioner’s record of accomplishment and the urgency of national health priorities made a waiver of the job offer requirement beneficial to the U.S.
Why This Petition Was Approved
Evidence
Similar Cases
Postdoctoral Researcher
Biotechnology · China
Postdoctoral Researcher
Biotechnology · Mexico
Research Scientist
Biotechnology · China
Research Fellow
Biotechnology · Taiwan
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-03.
Browse all casesAt a Glance
EB-2 (NIW) Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist